Emerging Non-Coding RNA Therapeutics Summit (Virtual Event)
Advance the Targeting of Non-Coding RNAs by Enhancing Target Specificity, Optimizing Formulation & Improving Efficacy for the Accelerated Translation of Safe & Effective Non-Coding RNA Therapeutics
As the RNA revolution continues off the back of the COVID-19 pandemic, large pharma and investors turn their attention to emerging non-coding RNA therapies beyond just mRNA.
Built with world-class biopharmaceutical industry insights, this industry-, therapeutic- and translational-focused meeting will set the scene for non-coding RNAs, such as lncRNAs and microRNAs, for their successful development into the clinic.
Expertise from new and emerging companies in this rapidly growing space will cover the identification, validation and development of nucleic acid targeting approaches of non-coding RNAs in broad range of diseases.